These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 37658546)
1. The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slices. Studley WR; Lamanna E; Martin KA; Nold-Petry CA; Royce SG; Woodman OL; Ritchie RH; Qin CX; Bourke JE Br J Pharmacol; 2024 Jul; 181(14):2287-2301. PubMed ID: 37658546 [TBL] [Abstract][Full Text] [Related]
2. The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice. Marshall SA; Qin CX; Jelinic M; O'Sullivan K; Deo M; Walsh J; Li M; Parry LJ; Ritchie RH; Leo CH Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32085666 [TBL] [Abstract][Full Text] [Related]
3. Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice. Qin CX; May LT; Li R; Cao N; Rosli S; Deo M; Alexander AE; Horlock D; Bourke JE; Yang YH; Stewart AG; Kaye DM; Du XJ; Sexton PM; Christopoulos A; Gao XM; Ritchie RH Nat Commun; 2017 Feb; 8():14232. PubMed ID: 28169296 [TBL] [Abstract][Full Text] [Related]
4. The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA. Cussell PJG; Howe MS; Illingworth TA; Gomez Escalada M; Milton NGN; Paterson AWJ PLoS One; 2019; 14(6):e0217815. PubMed ID: 31170199 [TBL] [Abstract][Full Text] [Related]
5. A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis. Kao W; Gu R; Jia Y; Wei X; Fan H; Harris J; Zhang Z; Quinn J; Morand EF; Yang YH Br J Pharmacol; 2014 Sep; 171(17):4087-96. PubMed ID: 24824742 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine kinase inhibitors relax pulmonary arteries in human and murine precision-cut lung slices. Rieg AD; Bünting NA; Cranen C; Suleiman S; Spillner JW; Schnöring H; Schröder T; von Stillfried S; Braunschweig T; Manley PW; Schälte G; Rossaint R; Uhlig S; Martin C Respir Res; 2019 Jun; 20(1):111. PubMed ID: 31170998 [TBL] [Abstract][Full Text] [Related]
7. The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Exhibits Anti-Inflammatory Activity in LPS-Stimulated Organotypic Hippocampal Cultures. Trojan E; Tylek K; Leśkiewicz M; Lasoń W; Brandenburg LO; Leopoldo M; Lacivita E; Basta-Kaim A Cells; 2021 Jun; 10(6):. PubMed ID: 34204273 [TBL] [Abstract][Full Text] [Related]
8. Intrapulmonary arterial contraction assay reveals region-specific deregulation of vasoreactivity to lung injuries. Bai Y; Li G; Yung L; Yu PB; Ai X Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L114-L124. PubMed ID: 37278410 [TBL] [Abstract][Full Text] [Related]
9. Highlights and hot topics in GPCR research from 'Down Under'. Smith NJ; May LT; Grimsey NL Br J Pharmacol; 2024 Jul; 181(14):2091-2094. PubMed ID: 38798136 [TBL] [Abstract][Full Text] [Related]
10. Targeting G protein-coupled receptors for heart failure treatment. Thai BS; Chia LY; Nguyen ATN; Qin C; Ritchie RH; Hutchinson DS; Kompa A; White PJ; May LT Br J Pharmacol; 2024 Jul; 181(14):2270-2286. PubMed ID: 37095602 [TBL] [Abstract][Full Text] [Related]
11. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1. Stenfeldt AL; Karlsson J; Wennerås C; Bylund J; Fu H; Dahlgren C Biochem Pharmacol; 2007 Oct; 74(7):1050-6. PubMed ID: 17692291 [TBL] [Abstract][Full Text] [Related]